XML 14 R4.htm IDEA: XBRL DOCUMENT v2.4.0.8
Condensed Consolidated Statements of Comprehensive Income (Loss) (Unaudited) (USD $)
In Thousands, except Share data, unless otherwise specified
 3 Months Ended 9 Months Ended
Sep. 29, 2013
Sep. 30, 2012
Sep. 29, 2013
Sep. 30, 2012
Revenues $ 20,361 $ 26,181 $ 58,659 $ 72,388
Cost of products sold 14,234 17,962 41,631 53,109
Gross profit 6,127 8,219 17,028 19,279
Operating expenses:        
Research and development (including $56, $65, $167 and $195, respectively, of amortization of intangible assets) 1,418 1,596 4,456 5,706
Selling, general, and administrative (including $46, $57, $134 and $177, respectively, of amortization of intangible assets) 4,057 4,869 13,419 16,041
Total operating expenses 5,475 6,465 17,875 21,747
Operating income (loss) 652 1,754 (847) (2,468)
Other income (expense):        
Interest income 13 1 27 4
Interest expense (66) (97) (199) (316)
Miscellaneous (8) (15) (31) 17
Income (loss) from continuing operations before income taxes 591 1,643 (1,050) (2,763)
Income tax provision (benefit)-current (19) 120 42 387
Income tax provision-deferred 3 55 93 50
Total income tax provision (benefit) (16) 175 135 437
Net income (loss) from continuing operations 607 1,468 (1,185) (3,200)
Discontinued operations:        
Income from discontinued operations, net of tax 15 200 159 178
Net income (loss) 622 1,668 (1,026) (3,022)
Net loss attributable to noncontrolling interest 22 11 31 31
Net income (loss) attributable to Ultralife 644 1,679 (995) (2,991)
Other comprehensive income (loss):        
Foreign currency translation adjustments 32 (204) 53 (81)
Comprehensive income (loss) loss attributable to Ultralife $ 676 $ 1,475 $ (942) $ (3,072)
Net income (loss) attributable to Ultralife common shareholders - basic        
Continuing operations (in Dollars per share) $ 0.04 $ 0.09 $ (0.07) $ (0.18)
Discontinued operations (in Dollars per share) $ 0.00 $ 0.01 $ 0.01 $ 0.01
Total (in Dollars per share) $ 0.04 $ 0.10 $ (0.06) $ (0.17)
Net income (loss) attributable to Ultralife common shareholders - diluted        
Continuing operations (in Dollars per share) $ 0.04 $ 0.09 $ (0.07) $ (0.18)
Discontinued operations (in Dollars per share) $ 0.00 $ 0.01 $ 0.01 $ 0.01
Total (in Dollars per share) $ 0.04 $ 0.10 $ (0.06) $ (0.17)
Weighted average shares outstanding - basic (in Shares) 17,467,000 17,418,000 17,461,000 17,390,000
Weighted average shares outstanding - diluted (in Shares) 17,532,000 17,418,000 17,461,000 17,390,000